Matthew Marshbanks, MD
Hospitalist · Louisville, KYNPI 1487783155
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Johnson & Johnson at 39.5% of the total. Reporting peaked in 2021 at $124 and has fallen 80.4% since, to $24 in 2025.
Across 16 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$129
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
- Novartis$39
- Boston Scientific$37
- Boehringer Ingelheim$14
- Novo Nordisk$13
What the payments were for
- Food & beverage$327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $96 |
| Novartis | 2 | $39 |
| Boston Scientific | 2 | $37 |
| Boehringer Ingelheim | 1 | $14 |
| Novo Nordisk | 1 | $13 |
How this compares
$327 in reported general payments places this provider in the 75th percentile of 258 hospitalist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,535 |
| Pantoprazole Sodium | 28 | $229 |
| Cefdinir | 19 | $127 |
| Furosemide | 30 | $102 |
| Metoprolol Succinate | 13 | $83 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $66 |
| Prednisone | 28 | $60 |
| Carvedilol | 14 | $55 |
| Atorvastatin Calcium | 15 | $51 |
| Amlodipine Besylate | 15 | $24 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Louisville
- Divyansh SharmaLouisville$3K
- Minh NguyenLouisville$2K
- Stephen RichardsLouisville$1K
- Jonathan RayLouisville$1K
- John BentonLouisville$906
- Stephen EdlingLouisville$638
- Ardel CagataLouisville$461
- Aftab AhmedLouisville$460
- Sergio CardinaliLouisville$390
- Troy MasdenLouisville$380
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.